CRISPR Therapeutics
| Use attributes for filter ! | |
| Stock price | CRSP |
|---|---|
| Disclaimer | |
| Headquarters | Zug |
| Switzerland | |
| Founded | 2013 |
| Subsidiaries | Casebia Therapeutics LLC |
| Casebia Therapeutics LLP | |
| CRISPR Therapeutics, Inc. | |
| Stock quote | CRSP |
| Disclaimer | |
| Ceo | Samarth Kulkarni |
| Founders | Emmanuelle Charpentier |
| Revenue | 1.2 million USD |
| Former | Inception Genomics |
| Number of employe | 458 |
| Date of Reg. | |
| Date of Upd. | |
| ID | 942429 |
About CRISPR Therapeutics
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases.
